Arie Mayer Net Worth & Insider Trades

Arie Mayer - Director, Oramed Pharmaceuticals Inc

As of April 20, 2023

What is Arie Mayer's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's Director, Arie Mayer, is estimated to be about $96.6K . Arie Mayer owns about 26,809 units of Oramed Pharmaceuticals Inc common stock. In the last 3 years at Oramed Pharmaceuticals Inc, Arie Mayer has sold an estimated value of $76.8K worth.

What is Arie Mayer's Past Insider Trading?

Arie Mayer's largest purchase order was 8,809 units , worth over $19.52K on April 4, 2023. Arie Mayer's largest sale order was 3,000 units , worth over $76.8K on May 10, 2022. In total, Arie Mayer has made about 6 transactions over 3 years of their time at Oramed Pharmaceuticals Inc. Arie Mayer usually trades in January and April, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Arie Mayer's' Mailing Address?

  • Mailing address is Moran 16 Kfar Saba L3 4428890 Israel

Oramed Pharmaceuticals Inc Executive Compensation

Option Awards
Other Compensation
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found


What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on April 4, 2023 by Arie Mayer who bought 8,809 units worth $19.52K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.61M worth of shares. Insider trading is most common in February and April, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO,  Miriam Kidron, Chief Scientific Officer,  and Leonard Sank, Director .


Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found